Lung ischemia-reperfusion injury (LIRI) and primary graft dysfunction are leading causes of morbidity and mortality among lung transplant recipients. Although extensive research endeavors have been undertaken, few preventative and therapeutic treatments have emerged for clinical use. Novel strategies are still needed to improve outcomes after lung transplantation. In this review, we discuss the underlying mechanisms of transplanted LIRI, potential modifiable targets, current practices, and areas of ongoing investigation to reduce LIRI and primary graft dysfunction in lung transplant recipients.
Ischemia-reperfusion Injury in the Transplanted Lung: A Literature Review
Tara Talaie,Laura Dichiacchio,Nikhil K. Prasad,C. Pasrija,W. Julliard,D. Kaczorowski,Yunge Zhao,C. Lau
Published 2021 in Transplantation Direct
ABSTRACT
PUBLICATION RECORD
- Publication year
2021
- Venue
Transplantation Direct
- Publication date
2021-01-07
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
CITED BY
Showing 1-47 of 47 citing papers · Page 1 of 1